Kedudukan dalam Saham
#27274
Lipum AB (publ) is a biopharmaceutical firm based in Sweden, focused on... Lipum AB (publ) is a biopharmaceutical firm based in Sweden, focused on pioneering the discovery and development of therapeutic solutions for long-term inflammatory conditions. The company's primary therapeutic asset, SOL-116, is a humanized antibody currently in the late preclinical stage, designed to treat pediatric rheumatism and adult rheumatoid arthritis. To facilitate the advancement of SOL-116 into clinical trials, Lipum has established a collaboration with Pelago Bioscience AB to meticulously monitor drug targets. Founded in 2010, the company's operations are headquartered in Umeå, Sweden.
Harga Saham
$1.60
Disegerakkan terakhir: 2026-03-18
Perubahan (1 tahun)
2.50%
Perdagangan Lipum AB (publ) (LIPUM)
Harga LIPUM dengan permodalan pasaran b
Modal pasaran bagi Lipum AB (publ)(LIPUM)
Modal Pasaran: $34.00M
Sehingga August 2026, Lipum AB (publ) mempunyai modal pasaran sebanyak $34.00M. Ini menjadikan Lipum AB (publ) syarikat ke-27274th paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran Lipum AB (publ) dari 2021 hingga 2026
LIPUM berbanding dengan 5 teratas yang paling popular stocks
| Harga LIPUM |
|
Aset B |
Pasaran B |
Hasilnya |
|
|
|
|
$5.301T
|
+15,589,977.50%
|
|
|
|
|
$4.634T
|
+13,628,302.52%
|
|
|
|
|
$4.143T
|
+12,184,582.16%
|
|
|
|
|
$3.589T
|
+10,556,397.47%
|
|
|
|
|
$2.857T
|
+8,402,307.07%
|
